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Cryptosporidiosis in Colombian children with HIV/AIDS infection
Carlos Alberto Velasco, MD1, Fabián Méndez, MD, PhD2, Pío López, MD3
SUMMARY
Introduction: Enteric cryptosporidiosis in children with HIV/AIDS is an important cause of morbidity and mortality.
Objective: To determine the prevalence of Cryptosporidium spp.  in feces, via the Ziehl Neelsen  modified technique,
among Colombian children with HIV/AIDS and to determine possible associations.
Methodology: Prevalence study in 131 children with HIV/AIDS at the Hospital Universitario del Valle in Cali, Colombia.
We evaluated clinical records, laboratory results, environmental factors, and socio-demographic variables. Statistical
analysis included the estimation of prevalence of infection in children and the corresponding 95% confidence interval;
estimation of other descriptive conditions of interest and the association analyses by multiple logistic regression.
Results: In this group of children with a mean age of 57 months, we found a prevalence of infection of 29%, more
frequently among male children and among those with vertical HIV transmission. The infection was also associated with
abdominal pain, having pets inside the house and C stage for HIV, with  >100,000 copies/ml of viral load and CD4 percentage
>25%. Association analysis showed a larger risk of Cryptosporidium infection with older age, and among patients not living
in Cali, with more severe status of HIV disease, previous hospitalizations, and dried oral mucosa. Factors found finally
associated were older age, chronic undernutrition, living in day-care institutions and having previous hospitalizations.
Conclusion: Almost a third of these children patients had Cryptosporidium infection, and it was found associated with
age, previous hospitalizations, chronic undernutrition and living in day-care institutions.
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Criptosporidiosis en niños colombianos con infección por VIH/SIDA
RESUMEN
Introducción: La criptosporidiosis entérica en niños infectados por VIH es una causa importante de enfermedad y muerte.
Objetivo: Determinar la prevalencia de Cryptosporidium spp. en heces por medio de la técnica de Ziehl Neelsen
modificada, en niños colombianos con infección por VIH/SIDA y establecer posibles asociaciones.
Metodología: Estudio de prevalencia en 131 niños con infección por VIH/SIDA. Fueron consideradas variables clínicas,
paraclínicas, ambientales y sociodemográficas. El análisis estadístico incluyó estimación de la prevalencia de infección en
los niños y su correspondiente intervalo de confianza al 95%, la estimación de otras medidas descriptivas de interés y el
análisis de asociación por regresión logística múltiple.
Resultados: En esta población de niños con una edad promedio de 57 meses se encontró una prevalencia de 29% de
infección, predominio del sexo masculino y el modo de transmisión vertical en VIH. La infección se asoció además con dolor
abdominal, tenencia de animales en el intradomicilio y a estadio C para VIH, con >100.000 copias/ml de carga viral y
porcentaje de CD4 >25%. En el análisis de asociación se encontró mayor oportunidad de infección por Cryptosporidium a
mayor edad, en los pacientes de fuera de Cali, con mayor severidad del estadío para VIH, con hospitalizaciones previas, y
con mucosa oral seca. Los factores finalmente asociados fueron la mayor edad, la DNT crónica, la convivencia en guarderías
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y las hospitalizaciones previas.
Conclusión: Casi una tercera parte de los pacientes
presentaron infección y esta se encontró asociada con la edad
del niño, con hospitalizaciones previas, con convivencia en
guarderías y DNT crónica.
Palabras clave: Cryptosporidium spp; Prevalencia;
Infección por VIH/SIDA; Niños.
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Cryptosporidium has been reported for causing
disease in humans since 1976. It is an important cause
of diarrhea in children with and without HIV infection
in developing countries, where the infection at early
ages has been reportedly associated to stunted physical
and cognitive growth1. In our experience, prevalence of
Cryptosporidium among immunocompetent children
varies between 4% and 32.3%, while among immuno-
compromised children it reaches values between 42
and 51.4%2,3. In particular, a study in Medellín, Colom-
bia, among 103 patients, 2-74 years of age, found
39.8% prevalence for Cryptosporidium spp. This was
the first study in Colombia, which achieved the
identification of C. hominis, C. parvum, and C. felis4.
Cryptosporidiosis is frequently associated to
persistent diarrhea disease (PDD) and undernutrition
(UNT) in immunologically compromised individuals,
like those with HIV/AIDS infection, in whom therapy
has not been effective5. However, it is also a serious
frequent cause of acute diarrhea disease (ADD) at all
ages of immunologically healthy individuals6. Until the
introduction of antiretroviral therapy (ART) between
1995 and 1996, it was a serious opportunistic infection,
which complicated HIV/AIDS infection. In immuno-
competent children, enteric cryptosporidiosis by C.
parvum induces light and self-limited gastroenteritis,
while in HIV-infected children it is severe, with
dehydration (DHT), and is associated to massive loss of
liquids6. Risk of infection is closely related to immune
disorders, mainly low count of CD4+ cells, and the
severity of the symptoms is associated to the number of
oocysts7. Although the therapeutic treatment is yet
unclear, the use of macrolides and thiazolides is an
alternative. Among children with HIV/AIDS infection,
the prevalence of Cryptosporidium spp. varies between
8% in the United States7 and 73.6% in Uganda4, with a
frequency of <1.0 per 100 individuals per year8,9. In our
experience, the prevalence of Cryptosporidium spp. in
feces via the modified Zielh Neelsen (ZN) technique, in
immunocompetent children from the municipality of
Piedecuesta in Santander was of 32.3% and only 4.0%
in the city of Cali in Valle del Cauca. Among immune-
compromised children with cancer at the Hospital Uni-
versitario de Santander in the city of Bucaramanga, in
northeastern Colombia, the prevalence was 42%, while
among children with HIV/AIDS infection Hospital
Universitario del Valle in the city of Cali, in the
southwest region of the country, it was 51.4% (95%
confidence interval CI: 39.9-62.9)2,3.
Little is known, however, about local risk factors
associated to this common cause of morbidity and
mortality among patients with immune disorders. Our
general objective was to determine the prevalence of
Cryptosporidium spp. in feces, via the modified ZN
technique, among a group of Colombian children with
HIV/AIDS infection under highly active antiretroviral
therapy (HAART), and to evaluate possible association
with socio-demographic, clinical, paraclinical, and
environmental factors.
METHODOLOGY
A prevalence study was conducted among children
below 15 years of age diagnosed with HIV/AIDS
infection and attending the HIV/AIDS Pediatric Clinic
at the «Hospital Universitario del Valle Evaristo García»
(HUV) in Cali, Colombia between February and April,
2009. We determined the presence and risk factors for
Cryptosporidium spp. infection without considering
seasonal climate changes, although they are well known
to influence presence of Cryptosporidium spp.,
especially after rainy seasons10 and in tropical regions,
like in our study area13. The target population was
children from the Colombian southwest and under
treatment or observation. The study included both male
and female children, <15 years of age, diagnosed with
HIV/AIDS infection through positive ELISA test,
positive confirming Western blot test, and positive
viral load (these tests taken at least 15 days before or
after taking feces to identify Cryptosporidium spp.).
Also, to be included, children must not have taken anti-
parasitic medications like nitazoxanide, corticosteroids
or antibiotics like azithromycin or paromomycin, 15
days prior to the determination of the Cryptosporidium
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spp. in feces. We excluded children with other confirmed
immunodeficiency and patients hospitalized because
of diseases concomitant to HIV/AIDS infection, which
place their lives at risk, like septic shock, severe hydro-
electrolyte or acid-alkaline imbalances. Assuming an
expected prevalence of 51%, with an estimation error
of +5%, and an α error of 0.05, a total population from
the HIV/AIDS Pediatric Clinic at HUV of 161 children
with HIV/AIDS infection by December 31, 2008, and
a 15% adjustment of losses of samples from the children,
or of no response, the sample size was of 131 children.
The main exposures of interest were the viral load
and the percentage of CD4 cells; while the evaluated
socio-demographic variables were age, gender, back-
ground, HIV mode of transmission; and the clinical
variables included the nutritional status (weight, height,
global undernutrition, chronic undernutrition, acute
undernutrition, overweight), gastrointestinal signs and
symptoms (acute diarrhea, chronic diarrhea, vomit,
abdominal pain, abdominal distension, enophthalmos,
acidotic breathing, distal perfusion, weeping without
tears, abdominal fold, dry oral mucosa), general
symptoms (fever), stage of HIV/AIDS infection,
hospitalizations; the paraclinical variables: viral load
for HIV, percentage of CD4, and environmental varia-
bles: household pets, consumption of potable water,
excreta disposal, overcrowding, stay in day-care center.
The result variable was the identification of Cryptos-
poridium spp. in at least one of the three slides of the
fresh feces samples collected, and processed via the
modified ZN technique14 one to three days after
interviewing each child in the study.
This work was approved by the Ethics Committee at
Universidad del Valle and at the HUV in Cali, Colom-
bia. The children’s parents or legal guardians who
accepted to participate signed a written informed consent
and answered a structured questionnaire applied by the
main researcher. After the survey, and during three
consecutive days, a fresh collection of fecal matter was
obtained labeled with non-sequential random numbers
and handed over to one of the two microbiology
bacteriologists who divided the sample on three slides.
The initial diagnosis of enteric cryptosporidiosis by
Cryptosporidium spp. was conducted on the fresh
collection sample of fecal matter from which three
extends were obtained through fixation and concen-
tration, via the modified ZN technique by the two
microbiology bacteriologists. The plates were revised
individually and separately by each of the two
microbiology bacteriologists; and in case of discrepant
results these were again checked to give a joint final
concerted verdict.
The database was in EpiInfo 6.04 and statistical
analysis was performed with Stata 10. To evaluate the
possibility of typing errors, 10% of the records were
checked and compared with the original forms and
corrected accordingly. To describe the distribution of
variables, exploratory analysis was performed of all the
variables. For the continuous variables, we obtained
plots (histograms, box and whisker plots, symmetry
plots), which permitted describing their distribution, as
well as the central tendency and dispersion measure-
ments. An analysis of normality was done and, if
needed, we developed data transformations for their
normalization. For categorical variables, we obtained
frequencies and proportions.
The HIV viral load variable was defined according
to four categories (<400 copies/ml; 401 and 29,999
copies/ml; 30,000 and 99,999 copies/ml; and >100,000
copies/ml), and the CD4 percentage was divided into
three categories (<15%, 15 and 24%, and >25%).
The nutritional status of the children of the study
was established by using reference tables from the
United States National Center for Health and Statistics
and the classifications by Gómez and Waterlow for
global undernutrition (UNT) according to weight for
age (1st degree or light = 10-24% deficit; 2nd degree or
moderate = 25-39% deficit; and 3rd degree or severe =
>40% deficit); chronic UNT according to height for age
(1st degree or light = 5-9%; 2nd degree or moderate = 10-
14%; and 3rd degree or severe >15% deficit); and acute
UNT according to weight for height (1st degree or light
= 10-19%, 2nd degree or moderate =20-29%, and 3rd
degree or severe >30% deficit). Overweight was defined
as a >10% weight for height excess.
We estimated the proportion of children with infec-
tion with its corresponding 95% confidence interval
(CI); and the descriptive measurements with their
corresponding standard deviations and ranges. To
evaluate infection risk factors, a univariate analysis
was initially performed between each of the exposure
variables of interest and the effect variable. We also
explored the possible association among the exposure
variables of greater interest (viral load and percentage
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of CD4) and other co-variables and between infection
by Cryptosporidium and the rest of the co-variables to
evaluate confounding. Odds ratios (OR) were estimated
with 95% CI, and statistical significance was evaluated
with Fisher’s exact test. For confounding and interaction
evaluation, we performed multiple logistic regression
analyses. To guide in obtaining the final multiple logistic
regression model, we used a backward stepwise
methodology with a probability of retirement of 0.10.
RESULTS
Between February and April of 2009, 161 children
were eligible and 131 were finally included in the study.
Some missing data was not available for some children
with information of weight for height nutritional status
(n=5), viral load (n=1), and CD4 percentage (n=8).
Among 38 children, at least one of corresponding
three examined slides were found positive for Cryptos-
poridium spp. (prevalence of infection 29%; 95%CI:
21.2-36.8), and they are considered as cases for further
analysis, while children with all three negative samples
(n=93) are considered controls. Table 1 describes main
characteristics of the study group. The average weight
was 15.2±7.7 kg (range of 4.1-45 kg); average height
was 96±22 cm (range of 54-165 cm); and 77.9% [CI
95% (70.8-85%)] of the children had been hospitalized
at least once after HIV/AIDS diagnosis. The average
viral load was 302,414±364,962 copies/ml (range of
39-1’500,000 copies/ml) and the mean percentage of
CD4 was 27%±13% (range of 2%-74%).
Association analysis. We found higher odds of
Cryptosporidium infection among older and male
children among those not living in Cali, with acute
UNT, in children presenting fever, dry oral mucosa,
weeping without tears, with a more severe stage of
disease, previous hospitalizations, and among those
children staying in day-care centers. Conversely, lower
odds of infection were found with global UNT, chronic
UNT, higher viral load, and lower CD4 percentage
(Table 2).
After controlling for potential confounders, the va-
riables best explaining the presence of Cryptosporidium
spp. were age, chronic UNT, stay in day-care centers,
and prior hospitalizations (Table 3), even when the
paraclinical variables, viral load and percentage of
CD4, were also included in the analysis (Table 4).
DISCUSSION
Various studies have evaluated the occurrence of
Cryptosporidium spp. in HIV-positive children. The
study by Dankner et al., included 3331 HIV positive
children in 13 clinical trials before HAART with an
average follow-up of 23.8 months and found 0.6
Cryptosporidium spp. infections per 100 child-years
(CI 95% 0.4-0.8)8. According to Tumwine et al.6, there
is 44.4 times greater odds (CI 95% 18.4-110.4 p<0.0001)
of presenting Cryptosporidium spp. in HIV-positive
children as compared to HIV-negative children. In the
current study, we found a 29.0% prevalence of
Cryptosporidium in feces using the modified ZN
technique, and our result is similar to the report by
Amadi et al.15, which identified a 28.84% prevalence of
Cryptosporidium spp. in 104 HIV-positive children
from Zambia. Additionally, they found a diagnosis of
persistent undernutrition-diarrhea syndrome, suggesting
a high prevalence of intestinal infectious disease, and
underpinning the importance of cryptosporidiosis as a
contributing factor in the physiopathology of this
syndrome.
Our prevalence triplicates that reported by Guarino
et al.7, who identified the presence of Cryptosporidium
spp. in 3 of 35 North American HIV-positive children
with diarrhea (8.6% prevalence); and who unlike our
study, identified Cryptosporidium spp. in 85% of feces
samples via immunofluorescence and only in 15% with
the modified ZN technique, which allows them to
conclude that enteric cryptosporidiosis is a severe
problem during advanced stages of HIV/AIDS infection.
Likewise, our prevalence doubles that reported by
Cegielski et al.5, of 13% in 3 of 23 HIV-positive
children from Tanzania with chronic diarrhea who –
unlike our study – identified Cryptosporidium spp. via
Kinyoun stain and monoclonal antibodies through direct
fluorescence; thus, for these authors, Cryptosporidium
spp. was considered an important pathogen in children
with chronic diarrhea and HIV/AIDS infection. Finally,
our prevalence is low, compared to the results by
Tumwine et al.6, in Uganda who reported 73.6%
Cryptosporidium spp., unlike our study, via immuno-
fluorescence and PCR in feces of 91 HIV-positive
children with persistent diarrhea and without
antiretroviral therapy, which (in part) for them could
explain the very high prevalence of this parasite in this
422
Colombia Médica                  Vol. 42 Nº 4, 2011 (Octubre-Diciembre)
Table 1
General characteristics of children with HIV/AIDS infection.
Hospital Universitario del Valle, Cali, Colombia 2008 (n=131)
All Cases Controls
(n=131) (n=38) (n=93) p
 C. spp. + C. spp. -
Age (months) 57.0±41.3 68.3±41.6 52.4±40.4
(1-173) (13-170) (1-173) 0.08
Gender (n,%)    
  Male 69 (52.7) 19 (50.0) 50 (53.8)
  Female 62 (47.3) 19 (50.0) 43 (47.2) 0.69
Place of origin (n,%)    
  Cali 56 (42.7) 37 (39.8) 19 (50.0)
  Valle 40 (30.5) 31 (33.3) 9 (23.7)
  Other 35 (26.7) 25 (26.9) 10 (26.3) 0.28
Mode of transmission (n,%)    
  Vertical 126 (96-18) 38 (100) 88 (94-62)
  Sexual 3 (2.3) 0 3 (3.2)
  Transfusion 2 (1.5) 0 2 (2.2) 0.36
Stage (n,%)    
  A 34 (25.9) 9 (23.7) 25 (26.9)
  B 33 (25.2) 6 (15.8) 27 (29.0)
  C 64 (48.8) 23 (60.5) 41 (44.1)
Signs and symptoms (n,%)    
  Abdominal pain 19 (14.5) 5 (13.2) 14 (15.1) 0.77
  Abdominal distension 16 (12.2) 3 (7.9) 13 (13.9) 0.33
  Acute diarrhea 13 (9.9) 3 (7.9) 10 (10.7) 0.33
  Fever 13 (9.9) 4 (10.5) 9 (9.7) 0.88
  Vomit 9 (6.9) 0 9 (9.7) 0.11
  Dry oral mucosa 4 (3.1) 2 (5.3) 2 (2.2) 0.34
  Chronic diarrhea 3 (2.3) 0 3 (3.2) 0.33
  Presence of tears 3 (2.3) 1 (2.6) 2 (2.2) 0.86
  Enophthalmos 2 (1.5) - 2 (2.2) 0.83
  Distal malperfusion 1 (0.8) - 1 (1.1) 0.88
  Abdominal fold present 1 (0.8) 1 (2.6) - 0.15
  Acidotic breathing 1 (0.8) 1 (2.6) - 0.15
  Nutritional status    
According to weight for age (n,%)    
  Eutrophic 35 (26.7) 10 (26.3) 25 (26.9)
  Light global UNT 49 (37.4) 18 (47.4) 31 (33.3)
  Moderate global UNT 41 (31.3) 9 (23.7) 32 (34.4)
  Severe global UNT 6 (4.6) 1 (2.6) 5 (5.9) 0.94
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Table 1
General characteristics of children with HIV/AIDS infection.
Hospital Universitario del Valle, Cali, Colombia 2008 (n=131) (continuation)
All Cases Controls
(n=131) (n=38) (n=93) p
 C. spp. + C. spp. -
According to height for age (n,%)    
  Eutrophic 48 (36.6) 16 (42.1) 32 (34.4)
  Light chronic UNT 26 (19.8) 9 (23.7) 17 (18.9)
  Moderate chronic UNT 40 (30.5) 11 (28.9) 29 (31.2)
  Severe chronic UNT 17 (12.98) 2 (5.26) 15 (16.13) 0.40
According to weight for height (n,%) (n=126) (n=36) (n=90)
  Eutrophic 68 (53.97) 18 (50) 50 (55.6)
  Light acute UNT 26 (20.63) 10 (27.78) 16 (17.8)
  Moderate acute UNT 11 (8.73) 2 (5.56) 9 (10.0)
  Severe acute UNT 2 (1.59) 1 (2.78) 1 (1.1)
  Overweight 19 (15.08) 5 (13.89) 14 (15.6) 0.57
Prior hospitalizations (n,%) 102 (77.86) 33 (86.84) 69 (74.2) 0.11
Viral load (copies/ml) (n,%) (n=130) (n=38) (n=92)
  <400 15 (11.54) 4 (10.53) 11 (11.9)
  >400-<30,000 26 (20) 9 (23.68) 17 (18.5)
  >30,000-<100,000 20 (15.38) 6 (15.79) 14 (15.2)
  >100,000 69 (53.08) 19 (50) 50 (54.4) 0.81
%CD4 (n,%) (n=123) (n=37) (n=86)
  <15 26 (21.14) 5 (13.51) 21 (24.4)
  >15-<25 30 (24.39) 12 (32.43) 18 (20.9)
  >25 67 (54.47) 20 (54.05) 47 (54.6) 0.17
Environmental variables (n,%)    
  Household pets 59 (45.04) 14 (36.84) 45 (48.4) 0.22
  Overcrowding 59 (45.04) 20 (52.63) 39 (41.9) 0.26
  Stay in day-care center 55 (41.98) 19 (50) 36 (38.7) 0.23
  W/out potable water 17 (12.98) 5 (13.16) 12 (12.9) 0.96
  W/out excreta disposal 13 (9.98) 4 (10.53) 9 (9.7) 0.88
group of children with immune-compromise for HIV/
AIDS infection.
Upon comparing the current prevalence of 29%
with the 51% reported in 2006 by Siuffi et al.3, in the
same population, we suggest this decrease in prevalence
of infection may be due to several reasons, among
others: different levels of precision due to different
sample sizes; an over or under diagnosis by the
bacteriologists in identifying Cryptosporidium spp. via
the modified ZN technique; a spread use of HAART
therapy that now diminishes the morbidity and mortality
of superimposed infections, and possible seasonal
changes at the moment of identifying Cryptosporidium
spp. in feces. Regarding the identification of
Cryptosporidium spp. via the modified ZN technique,
in this study from the same sample of fecal matter we
obtained three slides, which along with the poor
sensitivity of the test -even when taking the three
samples at different times, and the short duration of
oocysts excretion of Cryptosporidium spp.16, may
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Table 2
Association between the presence of Cryptosporidium spp. and the socio-demographic, clinical,
paraclinical, and environmental variables of children with HIV/AIDS infection.
Hospital Universitario del Valle, Cali, Colombia 2008
Socio-demographic variables C. spp. + C. spp. - Odds Ratio CI 95%            p
Age groups
  0-2 years (Infant) 8 34 1.00
  3-4 years (Pre-school) 9 26 1.47 [0.49-4.33] 0.48
  5-11 years (School age) 19 30 2.69 [1.02-7.03] 0.04
  12-14 years     (Adolescents) 2 3 2.83 [0.40-19.87] 0.29
Gender
  Male 19 50 1.00
  Female 19 43 0.86 [0.40-1.83] 0.69
Place of origin
  Cali 19 37 1.00
  Valle 9 31 0.56 [0.22-1.42] 0.22
  Other 10 25 0.77 [0.31-1.95] 0.59
Clinical Variables Nutritional status
according to P/Age (Global UNT)
  Eutrophic 10 25 1.00
UNT I (deficit >10%-<25%) 18 31 1.45 [0.56-3.69] 0.43
UNT II (deficit >25%-<40%) 9 32 0.70 [0.24-1.99] 0.50
UNT III (deficit >40%) 1 5 0.50 [0.05-4.83] 0.54
Nutritional status according to
T/Age (Chronic UNT)
  Eutrophic 16 32 1.00
  UNT I (deficit >5%-<10%) 9 17 1.05 [0.38-2.89] 0.91
  UNT II (deficit >10%-<15%) 11 29 0.75 [0.30-1.89] 0.55
  UNT III (deficit >15%) 2 15 0.26 [0.05-1.31] 0.10
Nutritional status according to
Weight/Height (Acute UNT
or overweight)
  Eutrophic 18 50 1.00
  UNT I (deficit 10%-19%) 10 16 1.73 [0.66-4.51] 0.25
  UNT II (deficit 20%-%) 2 9 0.61 [0.12-3.13] 0.56
  UNT III (deficit >30%) 1 1 2.77 [0.16-46.77] 0.47
  Overweight (excess >10%) 5 14 0.99 [0.31-3.14] 0.98
Signs and symptoms
  No 1
 Diarrhea 3 13 0.68 [0.17-2.64] 0.58
 Fever 4 9 1.09 [0.31-3.80] 0.88
  Abdominal pain 5 14 0.85 [0.28-2.56] 0.78
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explain the low prevalence we found in this study. To
diminish the possible affectations in the validity of our
study, perhaps due to information bias (poor
classification), due to the number of samples to be
evaluated (suggested minimum of two samples in
patients with immune compromise as in the case of
children with HIV/AIDS infection), we decided to
identify Cryptosporidium spp. in three slides from a
feces sample from each child.
The modified ZN technique was used in this study
Table 2
Association between the presence of Cryptosporidium spp. and the socio-demographic, clinical,
paraclinical, and environmental variables of children with HIV/AIDS infection.
Hospital Universitario del Valle, Cali, Colombia 2008 (continuation)
Socio-demographic variables C. spp. + C. spp. - Odds Ratio CI 95%            p
  Abdominal distension 3 13 0.52 [0.14-1.96] 0.34
  Dry oral mucosa 2 2 2.52 [0.34-18.63] 0.36
  Weeping without tears 1 2 1.22 [0.10-13.97] 0.86
  Vomit 0 9 0.21 [0.004-1.64] 0.11
  Enophthalmus 0 2 0.78 [0.01-10.16] 0.83
  Diminished distal perfusion 0 1 1.19 [0.01-23.49] 0.88
  Abdominal fold 1 0 4.94 [0.24-294.87] 0.15
  Acidotic breathing 1 0 4.94 [0.24-294.87] 0.15
Stage
  A 9 25 1.00
  B 6 27 0.61 [0.19-1.98] 0.41
  C 23 41 1.55 [0.62-3.89] 0.34
Hospitalizations
 No 1
  Yes 33 69 2.29 [0.80-6.55] 0.12
Paraclinical variables
Viral load (copies/ml)
  <400 4 11 1.00
  400-29,999 9 17 1.45 [0.35-5.90] 0.59
  30000-99,999 6 14 1.17 [0.26-5.23] 0.82
  >100,000 19 50 1.04 [0.29-3.68] 0.94
Percentage CD4 (%)
  <15 5   21 1.00
  15-24 12  18 2.80 [0.82-9.46] 0.09
  >25 20 47 1.78 [0.59-5.40] 0.30
Environmental variables
  No 1
  Household pets 14 45 0.62 [0.28-1.34] 0.23
  Potable water 33 81 0.97 [0.31-2.99] 0.96
  Excreta disposal 34 84 0.91 [0.26-3.15] 0.88
 Overcrowding 20 39 1.53 [0.72-3.28] 0.26
  Stay in day care centers 19 36 1.58 [0.74-3.38] 0.23
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Table 3
Factors associated to Cryptosporidium spp. incidence according to the socio-demographic,
clinical, and environmental variables of children with HIV/AIDS infection.
Hospital Universitario del Valle, Cali, Colombia 2008 (N= 131)
Variable Odds Ratio        CI 95%          p
Socio-demographic
   Age groups 1.86 [1.16-2.98] 0.01
Clinical
  Chronic UNT 0.67 [0.44-1.01] 0.05
   Prior hospitalizations 2.74 [0.91-8.24] 0.07
Environmental
   Stay in day care centers 2.11 [0.92-4.85] 0.07
Table 4
Factors associated to Cryptosporidium spp. incidence according to the socio-demographic,
clinical, and environmental variables of children with HIV/AIDS infection.
Hospital Universitario del Valle, Cali, Colombia 2008 (N= 122)
Variable Odds Ratio adjusted CI 95%              p
Socio-demographic
   Age groups  1.79 [1.12-2.86] 0.01
Clinical
   Chronic UNT 0.63 [0.41-0.96] 0.03
   Prior hospitalizations 2.62 [0.85-8.04] 0.09
Environmental
   Stay in day care centers 2.35 [1.00-5.52] 0.05
because of its high specificity (100%), although low
sensitivity (37%-77%)16-19. The test is relatively
unknown by most physicians20 and many laboratories
only analyze fecal samples for Cryptosporidium if
requested by the clinician21. However, most health
personnel believe cryptosporidiosis is a relatively rare
disease, which is mainly caused by drinking water or
exposure to swimming pools22.
The ZN diagnostic technique is troublesome because
of the short period of oocyst excretion and the time-
consuming analysis procedure. Nevertheless, rapid tech-
niques like immunoassays (ELISA)10 or direct immuno-
fluorescence have limited use in epidemiological and
diagnostic studies23. In consequence, and given that
experimental data support that oocyst could be
undetected by the ZN technique in 40-50% of individuals
with diarrhea, we concentrated the samples by
sporulation24 and, subsequently, identified the oocysts
by light microscopy25.
Risk factors
Age. Dankner et al.8 reported an age for acquiring
cryptosporidiosis of 5.9 years. The average age of our
patients was 4.8±3.4 years (range: 1 month-14.4 years);
while in the Cegielski et al., study it was 21 months5
(range 15-51 months), in the Tumwine et al. study6 it
was 14±9 months, in the Guarino et al. paper7 it was 17
months (range 2-155 months), and in the study by
Amadi et al.14, it was 18 months (range: 14-21 months).
In the statistical model of our study, older children were
at higher risk of Cryptosporidium spp. OR=1.79 [CI
95% 1.12-2.86] (p=0.01); according to data previously
reported by us2,3, we hypothesize this is at least in part
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explained by this group of children being more exposed
to parasite reservoirs
Gender. This study reports a slight predominance of
the male gender over the female, at a ratio of 1.1, as
described in studies by Dankner et al.8 and Tumwine et
al.6, and unlike that observed by Cegielski et al.5 and
Guarino et al.7; however, there are studies that do not
manage to explain the gender differences regarding the
presence of Cryptosporidium spp.12
Mode of transmission. This study revealed predo-
minance of the vertical mode of transmission, as reported
by Guarino et al.7, which according to Dankner et al.8,
permits a better interpretation of the results, given that
children infected through sexual contact later in life
represent a population with a different duration of the
infection. Our findings regarding mode of transmission
are as expected, bearing in mind our own previous
results2,3 and that over 90% of the cases of HIV/AIDS
infection in children is because of vertical transmission,
from the mother to the child, during child birth
(intrauterine), during labor, at delivery (intrapartum),
or postnatal through maternal breastfeeding.
Viral load and percentage of CD4. The study’s final
statistical model did not include the viral load or the
percentage of CD4 as risk factors in children with HIV/
AIDS infection to present Cryptosporidium spp.; data
initially reported by us2,3, and unlike that described by
Tumwine et al.6, who state that children low CD4
percentage (<15%) have 6.4 times the opportunity [CI
95% 0.64-64.74 p=0.114] of presenting Cryptospori-
dium spp. than children with CD4 >15%. Likewise, our
data suggest in the univariate analysis that as CD4
percentage increases, the chances for Cryptosporidium
spp. infection are lower: among children with %CD4
>15 and <25: OR=2.8 [CI 95%: 0.82 - 9.46; p=0.09];
and in those with %CD4 >25: OR=1.78 [CI 95% 0.59-
5.40; p=0.30]. This finding, apparently contradictory
with the natural history of the disease, could be simply
due to random effects or because our patients, unlike
the children from Uganda6, received antiretroviral
therapy, which could have favored increased percentage
of CD4 and their better evolution. Our findings are
paradoxical in that when our patients are included in the
study, they presented in 53.1% of the cases viral loads
over 100,000 copies/ml, meaning poor adherence to the
HAART therapy. This does not agree with the results of
CD4 percentage reported, which state the contrary.
This, we could probably interpret to the labile results of
the viral load to the HAART therapy, especially bearing
in mind that when the children were included in the
study, the viral load used had been 15 days before or
after taking the fecal matter sample. According to that
reported by Dankner et al.8, in children with HIV
infection and cryptosporidiosis, the mean %CD4 was
4%, while in our study this percentage was at 27±13%
(range of 2-74%); also, they reported the presence of
1.3 events per 100 individuals per year when the CD4
percentage is <15% and 0.2 events per 100 individuals
per year when the CD4 percentage is between 15-25%
and >25%. In our case, over half of the children studied
(54.47%), presented a CD4 percentage >25%.
Undernutrition. Upon comparing our results to that
reported by Amadi et al.15, and Tumwine et al.6, who
described severe acute undernutrition (UNT) in 22% of
the cases, severe global UNT in 47%, and severe
chronic UNT in 63%, our patients presented better
nutritional conditions and we did not find nutritional
status compromise of our patients in terms of severe
UNT; only 1.6% of them presented severe acute UNT,
4.6% severe global UNT, and 13% severe chronic
UNT, which permits us to conclude that the presence of
Cryptosporidium spp. is associated to UNT. These data
equally contradict that reported by Guarino et al.7 and
Ceigielski et al.5 In general, we could assume that the
nutritional status of the children from the study is
acceptable, especially if compared with our prior data
in this same group of children, who in 2005 presented
global UNT in 72% of the cases, chronic UNT in 67%,
and acute UNT in 35%, this is very probably secondary
to the efficacy and effectiveness of the HAART therapy,
and to the follow-up and control program at the HIV/
AIDS Pediatric Clinic at HUV, among others, which
permit greater adherence to therapy and diminished
morbidity and mortality in this group of children, which
is outlined by their better nutritional status. The
paradoxical protective effect found in our patients may
be interpreted more than merely as chronic UNT, as
being short stature for the age, whose causes are
multifactorial and not only due to UNT; causes among
which could be involved constitutional short stature,
short family stature, constitutional retarded develop-
ment, slow maturity, etc. In our particular case, and per
se, because of the short stature reported in children due
to the HIV/AIDS condition. It is also worth noting that
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the tables of reference used for the analysis of the
nutritional status of our children were those from the
United States National Center for Health and Statistics,
given that these are universally considered in most of
the studies reviewed and also because we used them
previously in other studies2,3.
Hospitalizations. In the study Cegielski et al.5, hos-
pital stay was significantly longer in the group of
children with cryptosporidiosis (average of 10 days;
range of 2-18 days) than in children without this infection
(average of 4 days; range of 1-17 days) (p=0.03). In our
study, children with prior hospitalizations have 2.75
times greater chance [CI 95% 0.89-8.46 p=0.07] of
having Cryptosporidium spp., which could be explained
not necessarily by what we would have expected, from
the potential severity of enteric cryptosporidiosis in
these types of patients, but rather, by the presence of co-
infections due to other pathogens or co-morbidity from
other conditions having to do with these types of
patients, which were not considered for this study. We
do not report any case of mortality during the study;
however, Amadi et al.15, describe 3.3 greater opportunity
of dying [CI 95% 1.6-6.85 p=0.001] in children with
Cryptosporidium spp. Again, the lack of deaths in our
study may reflect the better nutritional status of the
children included, better access to antiretroviral
therapies and to the healthcare institution, and to
adequate follow up within the HIV/AIDS Pediatric
Clinic at HUV in Cali, Colombia, among others.
Signs and symptoms. For Cegielski et al.5 clinically,
the distinctive findings were vomit and dehydration
among children with acute diarrhea who had
cryptosporidiosis; for us, fever [OR=1.09, (CI 95%
0.31-3.80) p=0.88)], dry oral mucosa [OR=2.52, (CI
95% 0.34-18.63) p=0.36], and weeping without tears
[OR=1.22, (CI 95% 0.10-13.97) p=0.86] were important
findings, but they were, nevertheless, statistically
insignificant. We only reported one child with dehy-
dration, but Tumwine et al.6, describe 7.4% of their
children with dehydration, and in their conclusions
they even identify severe dehydration as a bad prognosis
factor in children with HIV/AIDS infection and positive
Cryptosporidium [OR 0.63 (CI 95% 0.15-2.67)
p=0.526], as reported by Guarino et al.7, who associate
such dehydration to the secretor component and to the
persistence of diarrhea secondary to Cryptosporidium.
Stage. Our patients were predominantly stage C,
according to the classification from the United States
Center for Disease Control (CDC), as that described by
Guarino et al.7, but differing with their conclusions,
because the evolution of our patients was satisfactory,
while they not only found a clear association with the
advanced stage of the HIV/AIDS infection but also
with the rapid clinical and immunological compromise
of their patients; suggesting for them that the severe
disorder of the immune response is associated to
colonization and subsequent clinical disease, which
suggests them to propose that enteric cryptosporidiosis
should be considered a key point in the progression of
the HIV/AIDS infection.
Environmental. Cegielski et al.5 found no significant
associations among household pets, crawling children,
or walking children, or the type of or location of the bath
or water. In our final statistical model, we found that
children staying in day-care centers have 2.75 times
greater opportunity [CI 95% 1.12-6.72 p=0.02] of having
Cryptosporidium spp.; this is because of the possibility
of transmission among children attending day-care
centers as secondary cases and asymptomatic infections
among intra-family contacts; therein, the importance of
keeping children with diarrhea from attending these
daycare centers while they are sick.
Our recommendations are aimed at identifying the
taxonomic characteristics of the parasite in our environ-
ment through high-resolution molecular epidemiology,
which will help researchers to better understand its
transmission in children and, thus, once characterized,
associate it to the clinical manifestations of the different
Cryptosporidium spp. species and subtypes. Although
the highly active antiretroviral therapy (HAART) has
reduced the incidence of the disease in children with
HIV/AIDS infection, affecting the viral load, as well as
the parasite load of Cryptosporidium spp., future studies
could be guided towards the development of effective
therapeutic agents and drug therapies for human
cryptosporidiosis, particularly in patients with advanced
immune compromise due to HIV/AIDS infection;
thereby, diminishing their morbidity and mortality.
In conclusion, the prevalence of Colombian children
with HIV/AIDS infection under HAART therapy was
of 29%, with the variables that best explained the
presence of Cryptosporidium spp. included being older
than two years of age, presenting chronic UNT with a
deficit in height for age above 5%, staying in day-care
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centers, and having been previously hospitalized.
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